nirsevimab

N1I1R1S1E1V4I1M3A1B3

noun

A human recombinant monoclonal antibody used to prevent respiratory syncytial virus (RSV) infections in infants.

Scrabble 17

Meanings

nounnirsevimab (uncountable)
  1. uncountablemedicineA human recombinant monoclonal antibody used to prevent respiratory syncytial virus (RSV) infections in infants.

    There is another remedy under regulatory consideration, a monoclonal antibody shot developed by Sanofi and AstraZeneca, called nirsevimab. It is meant to be given at the hospital to babies who are born during the winter or in the fall, Jonathan Heinrichs, a Sanofi executive said in an interview.

    2023 May 18, Christina Jewett, “F.D.A. Panel Recommends R.S.V. Vaccine to Protect Young Infants”, in The New York Times

Origin

Cite this entry
APA

nirsevimab. (n.d.). In WatkinsX Dictionary. Retrieved November 3, 2026, from https://dictionary.watkinsx.com/word/nirsevimab

MLA

“nirsevimab.” WatkinsX Dictionary, https://dictionary.watkinsx.com/word/nirsevimab. Accessed November 3, 2026.

Chicago

WatkinsX Dictionary, s.v. “nirsevimab,” accessed November 3, 2026, https://dictionary.watkinsx.com/word/nirsevimab.

Source: nirsevimab on Wiktionary, CC BY-SA 4.0.